153 related articles for article (PubMed ID: 28428051)
21. [Fundamental studies on intravesical instillation of 4'-epi-adriamycin for the treatment of bladder cancer].
Tsushima T
Hinyokika Kiyo; 1985 Nov; 31(11):1945-56. PubMed ID: 3867286
[TBL] [Abstract][Full Text] [Related]
22. R11 modified tumor cell membrane nanovesicle-camouflaged nanoparticles with enhanced targeting and mucus-penetrating efficiency for intravesical chemotherapy for bladder cancer.
Zheng B; Liu Z; Wang H; Sun L; Lai WF; Zhang H; Wang J; Liu Y; Qin X; Qi X; Wang S; Shen Y; Zhang P; Zhang D
J Control Release; 2022 Nov; 351():834-846. PubMed ID: 36191674
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of transduction efficiency using Adeno-associated viral vectors by chemical pretreatment to mice bladder urothelium.
Hamada A; Kita Y; Murakami K; Matsumoto K; Sakatani T; Sano T; Ogawa O; Kobayashi T
J Virol Methods; 2020 May; 279():113854. PubMed ID: 32198026
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloprotein-triggered, cell penetrating peptide-modified star-shaped nanoparticles for tumor targeting and cancer therapy.
Guo F; Fu Q; Zhou K; Jin C; Wu W; Ji X; Yan Q; Yang Q; Wu D; Li A; Yang G
J Nanobiotechnology; 2020 Mar; 18(1):48. PubMed ID: 32183823
[TBL] [Abstract][Full Text] [Related]
25. Pannexin 1 channels mediate the release of ATP into the lumen of the rat urinary bladder.
Beckel JM; Daugherty SL; Tyagi P; Wolf-Johnston AS; Birder LA; Mitchell CH; de Groat WC
J Physiol; 2015 Apr; 593(8):1857-71. PubMed ID: 25630792
[TBL] [Abstract][Full Text] [Related]
26. Targeting urothelium: ex vivo assay standardization and selection of internalizing ligands.
Ardelt PU; Wood CG; Chen L; Mintz PJ; Moya C; Arap MA; Wright KC; Pasqualini R; Arap W
J Urol; 2003 Apr; 169(4):1535-40. PubMed ID: 12629410
[TBL] [Abstract][Full Text] [Related]
27. Effect of mucosal removal on the response of the feline bladder to pharmacological stimulation.
Levin RM; Wein AJ; Krasnopolsky L; Atta MA; Ghoniem GM
J Urol; 1995 Apr; 153(4):1291-4. PubMed ID: 7869530
[TBL] [Abstract][Full Text] [Related]
28. Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery.
Desai P; Patlolla RR; Singh M
Mol Membr Biol; 2010 Oct; 27(7):247-59. PubMed ID: 21028936
[TBL] [Abstract][Full Text] [Related]
29. Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules.
He B; Jabouille A; Steri V; Johansson-Percival A; Michael IP; Kotamraju VR; Junckerstorff R; Nowak AK; Hamzah J; Lee G; Bergers G; Ganss R
J Pathol; 2018 Jun; 245(2):209-221. PubMed ID: 29603739
[TBL] [Abstract][Full Text] [Related]
30. Mucosal signaling in the bladder.
Chai TC; Russo A; Yu S; Lu M
Auton Neurosci; 2016 Oct; 200():49-56. PubMed ID: 26422993
[TBL] [Abstract][Full Text] [Related]
31. Bladder tissue pharmacokinetics of intravesical taxol.
Song D; Wientjes MG; Au JL
Cancer Chemother Pharmacol; 1997; 40(4):285-92. PubMed ID: 9225946
[TBL] [Abstract][Full Text] [Related]
32. Optimization and internalization mechanisms of PEGylated adenovirus vector with targeting peptide for cancer gene therapy.
Yao XL; Yoshioka Y; Ruan GX; Chen YZ; Mizuguchi H; Mukai Y; Okada N; Gao JQ; Nakagawa S
Biomacromolecules; 2012 Aug; 13(8):2402-9. PubMed ID: 22746837
[TBL] [Abstract][Full Text] [Related]
33. Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide.
Mashreghi M; Faal Maleki M; Karimi M; Kalalinia F; Badiee A; Jaafari MR
J Drug Target; 2021 Jul; 29(6):617-630. PubMed ID: 33393376
[TBL] [Abstract][Full Text] [Related]
34. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is released by female mouse bladder urothelial cells and expressed by the urothelium as an early response to lipopolysaccharides (LPS).
Li Y; Lu M; Alvarez-Lugo L; Chen G; Chai TC
Neurourol Urodyn; 2017 Apr; 36(4):1020-1025. PubMed ID: 27337494
[TBL] [Abstract][Full Text] [Related]
35. Sensory dysfunction of bladder mucosa and bladder oversensitivity in a rat model of metabolic syndrome.
Lee WC; Chiang PH; Tain YL; Wu CC; Chuang YC
PLoS One; 2012; 7(9):e45578. PubMed ID: 23029112
[TBL] [Abstract][Full Text] [Related]
36. [Autoradiographic studies on the protective effect of mesna in the urinary bladder mucosa of the rat during administration of cyclophosphamide (preliminary communication)].
Kunze E; Köhnecke B; Engelhardt W; Brock N; Pohl J
Arzneimittelforschung; 1983; 33(6):853-4. PubMed ID: 6412725
[TBL] [Abstract][Full Text] [Related]
37. Investigating detrusor muscle concentrations of oxybutynin after intravesical delivery in an ex vivo porcine model.
Williams NA; Lee KM; Allender CJ; Bowen JL; Gumbleton M; Harrah T; Raja A; Joshi HB
J Pharm Sci; 2015 Jul; 104(7):2233-40. PubMed ID: 25989054
[TBL] [Abstract][Full Text] [Related]
38. Contractile properties of the pig bladder mucosa in response to neurokinin A: a role for myofibroblasts?
Sadananda P; Chess-Williams R; Burcher E
Br J Pharmacol; 2008 Apr; 153(7):1465-73. PubMed ID: 18264120
[TBL] [Abstract][Full Text] [Related]
39. Bladder wall penetration of intravesical mitomycin C in dogs.
Wientjes MG; Dalton JT; Badalament RA; Drago JR; Au JL
Cancer Res; 1991 Aug; 51(16):4347-54. PubMed ID: 1907883
[TBL] [Abstract][Full Text] [Related]
40. Temperature-responsive silk-elastinlike protein polymer enhancement of intravesical drug delivery of a therapeutic glycosaminoglycan for treatment of interstitial cystitis/painful bladder syndrome.
Jensen MM; Jia W; Schults AJ; Isaacson KJ; Steinhauff D; Green B; Zachary B; Cappello J; Ghandehari H; Oottamasathien S
Biomaterials; 2019 Oct; 217():119293. PubMed ID: 31276948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
